PRESS

The Disruptor - Pain Market Dominator

February 2019

C3 International, Inc Commissions Industrial - Scale Custom Extraction Laboratory from ENTEXS

10/20/2020

"World's Most Dangerous Man" Ken Shamrock Joins C3 International Board of Advisors

02/17/2020

Olympic Hall of Fame Inductee Gary Hall Jr. Joins C3 International Board of Advisors

12/09/2019 

Former NFL Player Kassim Osgood Joins the C3 International Board of Advisors

11/01/2019

Florida hosts American Priority Conference, in Miami

10/14/2019

This is the "Third Way" Solution to the Opioid Crisis

09/24/2019

How Understanding CECD Can Alleviate Anxiety Disorders

02/22/2019

Idrasil Could Be The First Standardized Medical Marijuana Prescription Pill 

11/18/2018

 Ever heard of CECD? Most people haven’t. It stands for Clinical Endocannabinoid Deficiency, and it’s more important to healthcare than people realize. 

11/12/2018

The need for product purity and doctor supervision led C3® International to create Idrasil™, the first prescription-only cannabis tablet. C3 was founded by Steele Clarke Smith III and Theresa Ann Smith, who serve as the company’s Chairman/CEO and President, respectively.

10/26/201

Idrasil™ is a medical phenomenon because it treats a wide range of ailments and pain stemming from AIDS, anorexia, arthritis, autism, anxiety/depression, cancer, chronic pain, glaucoma, migraines, persistent muscle spasms; Parkinson’s disease, seizures, severe nausea, and Tourette’s syndrome. Idrasil™ 

10/17/2018

Garden Grove, USA-based cannabis firm C3 International has launched a new product, Idrasil, in the US 

10/09/2019

“Smoking and edible confections can vary greatly from plant to plant and batch to batch, which results in inconsistency and can lead to irregular analgesic or therapeutic results” 

10/04/2018

C3 International, a California-based cannabinoid therapeutics-focused biopharmaceutical company 

09/29/2018

Pot Stocks, ETFs, Top News and Data from the Cannabis Industry

09/28/2018

 C3 International, a California-based cannabinoid therapeutics-focused biopharmaceutical company, officially announced the launch of its flagship Rx pain management pill, Idrasil.  

09/28/2018

Pot Stocks, ETFs, Top News And Data From The Cannabis Industry

09/28/2018

The first standardized and consistent form of prescription medical cannabis

09/28/2018

...another effective way to minimize stress and manage a number of health conditions (including anxiety) is medical marijuana. 

09/26/2018

Holistic alternative to opiates and narcotics with measurable dosages for the injured, sick and dying

09/17/2018

This is a day that would have made Dennis Peron, a historically heroic activist for medical marijuana, jump for joy.

09/2018

C3 International Inc., manufacturer of Idrasil™, the first natural cannabis tablet on the market, has published a white paper revisiting the effects of cannabis-based therapy in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions.

August 19, 2014

Release: Idrasil, Cannabis in a Pill Founder to exhibit at the Rx for Wealth Symposium April 27 in Huntington Beach.

 April 23, 2013 

Idrasil, a full-spectrum cannabinoid pill, satisfies the medical community with its standardized 25 mg tablet. 

 May 05, 2012 

United States of America v. Steele Smith Steele Clark Smith III.

 May 17, 2010
 

C3 International Introduces Idrasil: the First Standardized Form of Prescription Medical Cannabis in a Pill

Sept 17, 2018 

Orange County's Leading Source of News, Culture and Entertainment

April 14, 2011

U.S.A. v. Smith et al is a landmark cannabis case that could change federal medicinal marijuana law for all 50 states.

03/2009